Advert - LEO Pharma – Case AUTH/3503/4/21

• Date posted
  16 June 2023
• Sanction
  Advertisement,
• Case number/s
  AUTH/3503/4/21 - Complainant v Leo

For the unbalanced and misleading presentation of information and the failure to provide up-to-date safety information in relation to its website promoting Kyntheum (brodalumab), Leo was ruled in breach of the following clauses of the 2019 Code:

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical
industry
Clause 3.2 - Promotion inconsistent with the SPC
Clause 4.10 - Failing to show an inverted black equilateral triangle to denote that
additional monitoring is required in relation to adverse reactions
Clause 7.2 - Making misleading claims
Clause 7.3 - Making misleading comparisons
Clause 7.4 - Making unsubstantiated claims
Clause 7.9 - Making a claim that did not reflect the available evidence regarding
possible adverse reactions
Clause 7.10 - Not encouraging the rational use of the medicine
Clause 9.1 - Failing to maintain high standards